We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Cardiology

Journal Scan / Research · November 10, 2016

Everolimus-Eluting Stents Noninferior to CABG in Outcomes at 3 Years

The New England Journal of Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

The New England Journal of Medicine
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease
N. Engl. J. Med 2016 Oct 31;[EPub Ahead of Print], GW Stone, JF Sabik, PW Serruys, CA Simonton, P Généreux, J Puskas, DE Kandzari, MC Morice, N Lembo, WM Brown, DP Taggart, A Banning, B Merkely, F Horkay, PW Boonstra, AJ van Boven, I Ungi, G Bogáts, S Mansour, N Noiseux, M Sabaté, J Pomar, M Hickey, A Gershlick, P Buszman, A Bochenek, E Schampaert, P Pagé, O Dressler, I Kosmidou, R Mehran, SJ Pocock, AP Kappetein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading